Early Phase 1 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your blood counts, liver function, kidney function, and blood clotting results must meet certain healthy levels as measured by routine lab tests (confirm with trial site for exact values).
- Your heart must be functioning normally.
- You are expected to live for at least 12 weeks or more.
- You are able and willing to attend follow-up appointments as required.
- You have at least one tumor area that can be measured using standard imaging guidelines.
- If you are a woman between 18 and 49 years old who could become pregnant, you must have a negative pregnancy test within 7 days before the study examination.
- If you could become pregnant or father a child, you must agree to use effective birth control during the study and for 3 months after the examination.
- Your doctor has recommended a PET/CT scan (a type of detailed body imaging) to help diagnose or stage your cancer.
- You fully understand the study, are willing to take part, and are able to sign a consent form.
Who may not be able to join:
- You have serious problems with your liver, kidneys, or blood function.
- You are planning to become pregnant.
- You are currently pregnant or breastfeeding.
- You are unable to lie flat and still for 30 minutes.
- You do not wish to take part in the study.
- You have claustrophobia (fear of enclosed spaces) or other mental health conditions that may affect participation.
- The study doctor believes there is any other reason you should not participate (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18811177191
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Standardized Uptake Value (SUV) of target or suspected tumor lesions in malignant tumor subjects for 68Ga/18F-CAIX-LT-BCH across imaging time points
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.